U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

OPHIOCORDYCEPS SINENSIS

MORE DETAILS

8Q1GYP08KU

structurally diverse
Status:
Possibly Marketed Outside US
Source:
NCT04645407: Phase 4 Interventional Completed Novel Coronavirus Pneumonia
(2020)
Source URL:
https://clinicaltrials.gov/ct2/show/NCT04645407
First approved in 2011
Source:
21 CFR 352
Source URL:
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6774a54e-5328-44a0-8402-e859c93716c2
Class:
STRUCTURALLY DIVERSE
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966